
Arvind Dasari, MD, MS, explains how to sequence radioligand therapy, cabozantinib, and everolimus in well-differentiated neuroendocrine tumors.
Walter J. Curran, Jr, MD, discusses a study that looked at radiation therapy with or without procarbazine, CCNU, and vincristine (PCV) for the treatment of low-grade glioma.
Walter J. Curran, Jr, MD, Lawrence W. Davis Professor and Chair, Department of Radiation Oncology, Emory University School of Medicine, executive director, chair, Cancer Research, Winship Cancer Institute of Emory University, discusses a study that looked at radiation therapy with or without procarbazine, CCNU, and vincristine (PCV) for the treatment of low-grade glioma.






